Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd > hey Blig, take a look at agn's one month chart

<< Previous

Bullboard Posts

Next >>

Comment by bligickaon Jun 18, 2020 10:01am

63 Views

Post# 31164279

RE:hey Blig, take a look at agn's one month chart

And they didn't dilute huge .....so in 4 months when 80 million cheapies are free trading we will be at .05

bigbanktheory wrote: they announced a pp a while ago, stock went from .58 to .21, are you expecting the same thing here, and how can this maybe de avoided, possibly with some good news i hope

<< Previous

Bullboard Posts

Next >>

Corus reports Q1 profit drop in the face of falling revenue